| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Vaxart, Inc. | Director | Common Stock | 6.22K | $4.71K | $0.76 | Aug 4, 2022 | Direct |
| Vaxart, Inc. | Director | Stock Option (right to buy) | 37.3K | Aug 4, 2022 | Direct | ||
| Elevation Oncology, Inc. | Director | Stock Option (Right to Buy) | 0 | Jul 23, 2025 | Direct | ||
| Mirati Therapeutics, Inc. | Director | Common Stock | 0 | $59.02 | Jan 23, 2024 | Direct | |
| Mirati Therapeutics, Inc. | Director | Option to Purchase Common Stock | 0 | Jan 23, 2024 | Direct |